|
|||||||||||||||
Sexually
Transmitted Diseases > Screening
Tests > Consultants
Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections - 2002
ConsultantsExternal Consultants: Association of Public Health Laboratories, Washington, D.C. (no reviewers identified); Dana Best, M.D., Agency for Healthcare Research and Quality, Rockville, Maryland; Margaret C. Fisher, M.D., and Leonard Weiner, M.D., American Academy of Pediatrics, Elk Grove Village, Illinois; Luella Klein, M.D., American College of Obstetricians and Gynecologists, Washington, D.C.; Roxanne Shively, Food and Drug Administration, Rockville, Maryland; Aggie Clark, University of Washington, Seattle, Washington; Dennis V. Ferrero, M.P.H., San Joaquin County Regional Public Health Laboratory, Stockton, California; Charlotte A. Gaydos, Dr.P.H., Johns Hopkins University, Baltimore, Maryland; Anne Haddix, Ph.D., Emory University, Atlanta, Georgia; Margaret R. Hammerschlag, M.D., State University of New York, Brooklyn, New York; Doug R. Harger, Oregon Health Division, Portland, Oregon; Edward W. Hook, III, M.D., University of Alabama at Birmingham, Birmingham, Alabama; J. Mehsen Joseph, Ph.D., Maryland Department of Health and Mental Hygiene, Baltimore, Maryland; Robert B. Jones, M.D., Ph.D., Indiana University, Indianapolis, Indiana; James A. Kellogg, Ph.D., York Hospital, York, Pennsylvania; Barry P. Katz, Ph.D., Indiana University, Indianapolis, Indiana; David H. Martin, M.D., Louisiana State University, New Orleans, Louisiana; Toby Merlin, M.D., Lovelace Health Systems and CIGNA Healthcare of Arizona, Albuquerque, New Mexico; William C. Miller, M.D., Ph.D., University of North Carolina, Chapel Hill, North Carolina; Pamela G. Nathanson, Family Planning Council, Inc., Philadelphia, Pennsylvania; Albert Rabinovitch, M.D., Ph.D., Specialty Laboratories, Inc., Santa Monica, California; Julius Schachter, Ph.D., University of California at San Francisco, San Francisco, California; Karla Schmitt, Ph.D., Florida Department of Health, Tallahassee, Florida; Michael R. Skeels, Ph.D., Oregon State Public Health Laboratories, Portland, Oregon; Walter E. Stamm, M.D., University of Washington, Seattle, Washington; Barbara van der Pol, Indiana University, Indianapolis, Indiana; Jo Ann Yatabe, Ph.D., Specialty Laboratories, Inc., Santa Monica, California. CDC Consultants: Timothy A. Green, Ph.D., Epidemiology Program Office, John R. Astles, Ph.D., Nancy L. Anderson, M.M.Sc., and Rhonda S. Whalen, M.S., Public Health Practice Program Office.
Date last reviewed: October 18, 2002 Content Source: MMWR October 18, 2002 / Vol. 51 / No. RR--15 Content Owner: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention |
|||||||||||||||
|
|||||||||||||||